Discover 2,242 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Jose currently offers many active clinical trials with a particular emphasis on diabetes, Parkinson’s disease, Alzheimer’s disease, and cardiovascular conditions. Whether you’re looking for trials related to a specific health condition or interested in paid research as a healthy volunteer, San Jose’s diverse studies provide a variety of choices to explore new treatments while contributing to the future of medicine.
Filter
2
Filter results
Results: 2,242
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
for
Chronic Kidney Disease (CKD)
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70
Code: NCT05106387
Recruiting
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
for
Craniofacial Pain, Migraine, Cluster Headache,
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 18 - 70+
Code: NCT04930887
Phase 2, Recruiting
MCT for the Harvard/UCSF ROBIN Center
for
Glioma, Childhood Brainstem, Neuroblastoma
Location: San Francisco CA, Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 0+
Code: NCT06000787
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Stanford CA, Sacramento CA, Orange CA, Aurora CO,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06128551
Phase 1, Phase 2, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Location: Stanford CA, San Francisco CA, Los Angeles CA,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06915753
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for
Carcinoma, Non-small-Cell Lung
Location: Stanford CA, Orange CA, La Jolla CA, Seattle WA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05498428
Phase 2, Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Palo Alto CA, Kansas City KS, Houston TX, St Louis MO,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase 1, Recruiting
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
for
Breast Cancer
Location: Palo Alto CA, Anaheim CA, Pierre SD, Mitchell SD,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07405801
Phase 2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Palo Alto CA, Vallejo CA, Santa Monica CA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Oakland CA, San Francisco CA, Sacramento CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
for
Locally Advanced Pancreatic Adenocarcinoma
Location: Stanford CA, Scottsdale AZ, Detroit MI, Pittsburgh PA,
Sponsor: EXACT Therapeutics AS
Sex: All
Age: 18+
Code: NCT06850623
Phase 2, Recruiting
Peripheral Bypass Trial for Completion Control
for
Chronic Limb-Threatening Ischemia
Location: San Francisco CA
Sponsor: Medistim ASA
Sex: All
Age: 18+
Code: NCT06264843
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Palo Alto CA, Orange CA, Laguna Hills CA, San Diego CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
for
Lymphoma, Lymphoma, Non Hodgkin
Location: Palo Alto CA, Vancouver, Houston TX, St Louis MO,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07082803
Phase 1, Recruiting
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
for
Lymphedema, Breast Cancer, Lymphedema
Location: San Francisco CA
Sponsor: Stanford University
Sex: Female
Age: 18 - 70+
Code: NCT05366699
Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Dublin CA, Oakland CA, Emeryville CA, Walnut Creek CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase 2, Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
for
Uveal Melanoma
Location: Palo Alto CA, Riverside CA, Scottsdale AZ, Aurora CO,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07015190
Phase 3, Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for
Prostate Cancer Metastatic
Location: Palo Alto CA, Riverside CA, Las Vegas NV, Portland OR,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136624
Phase 3, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Palo Alto CA, San Francisco CA, Sacramento CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase 3, Recruiting
Rett Syndrome Registry
for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Oakland CA, Los Angeles CA, San Diego CA, Denver CO,